Show Notes
In this episode, Julia Rawlinson speaks with Professor Paul Little, is a Professor of Primary Care Research at the University of Southampton and a practising GP with over 20 years of clinical experience, about his landmark research on acute respiratory tract infections and its relevance for general practice. Professor Little summarises the Lancet Respiratory Medicine trial involving nearly 14,000 participants at risk of respiratory infections. The trial compared usual care, two nasal sprays (Vicks First Defense and isotonic saline), and a digital lifestyle intervention. Both nasal sprays resulted in fewer days ill, reduced antibiotic use by around 30%, and were well tolerated. The saline spray was highlighted as a first-choice option due to its effectiveness and minimal side effects. Giving practical advice on counselling patients to use nasal sprays at the first sign of illness, with discussion around challenges to adherence and the rationale for early use. They also explore the antiviral mechanism of saline spray and the continued value of stress management and physical activity in infection prevention. Professor Little discusses how setting realistic expectations about infection duration can help reduce unnecessary presentations and prescribing, and how these simple interventions contribute to antibiotic stewardship in primary care.
Links & Resources: https://www.southampton.ac.uk/people/5wzg2s/professor-paul-little#publications 12 month follow-up of a randomised open label trial of nasal sprays and a behavioural intervention for respiratory tract infections (RTIs) in primary care: https://eprints.soton.ac.uk/507356/
The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!
More from The Good GP
In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.
In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).
In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis.